BusinessPhase 1 clinical trial shows safety and immunogenicity of microneedle patch for flu vaccination for the first timeBy Nasdaq OMXJun 28, 2017, 10:00 AM UTC
BusinessZynerba Pharmaceuticals Initiates ZYN001 Phase 1 Clinical ProgramBy Nasdaq OMXJun 26, 2017, 11:30 AM UTC
BusinessRadioMedix Inc. and AREVA Med Announce Completion of the Exploratory Clinical Trial of 203Pb-AR-RMX in patients expressing somatostatin receptor positive neuroendocrine tumorsBy Nasdaq OMXJun 22, 2017, 8:00 PM UTC
BusinessSummit Presents Data From Phase 1 Clinical Programme of Ezutromid at the European Paediatric Neurology Society CongressBy Nasdaq OMXJun 22, 2017, 11:00 AM UTC
BusinessGalectin Therapeutics Announces Important Milestones towards Completion of NASH CX TrialBy Nasdaq OMXJun 13, 2017, 12:30 PM UTC
BusinessSummit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMDBy Nasdaq OMXMay 15, 2017, 11:01 AM UTC
BusinessSummit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMDBy Nasdaq OMXMay 15, 2017, 11:01 AM UTC
BusinessCellular Biomedicine Group (CBMG) Announces the Addition of a Second Clinical Site in the Expansion of its Chimeric Antigen Receptor T-cell (CAR-T) Phase I Clinical Trial for Its CARD-1 Trial in Patients with Non-Hodgkin Lymphoma (NHL)By Nasdaq OMXMay 15, 2017, 10:22 AM UTC
